Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana and Strive Health Announce Expansion of Holistic, Patient-Centered Care for People with Kidney Disease
Humana and Strive Health Announce Expansion of Holistic, Patient-Centered Care for People with Kidney Disease


Leading health and well-being company Humana Inc. (NYSE: HUM) and kidney care provider Strive Health have announced a new value-based care multi-state agreement for most Humana Medicare Advantage

Simulations Plus and the University of Bath Awarded New FDA Grant
Simulations Plus and the University of Bath Awarded New FDA Grant


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that

Premier, Inc. to Participate in Barclays Global Healthcare Conference on March 12, 2024
Premier, Inc. to Participate in Barclays Global Healthcare Conference on March 12, 2024


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Barclays

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 (the

LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova to Present at the Barclays Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers:
Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers


Agilent Technologies Inc. (NYSE: A) today announced the selection of Distinguished Professors Michel Barsoum and Yury Gogotsi at Drexel University and Professor Ananda Amarasekara at Prairie View

EQS-News: MEDICLIN presents preliminary figures for the 2023 financial year
EQS-News: MEDICLIN presents preliminary figures for the 2023 financial year
EQS-News: MEDICLIN presents preliminary figures for the 2023 financial year
Acadia Healthcare to Participate in Raymond James 45th Annual Institutional Investors Conference
Acadia Healthcare to Participate in Raymond James 45th Annual Institutional Investors Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the Raymond James 45th Annual Institutional Investors Conference, which is being held March 3 - 6

EQS-News: Eckert & Ziegler Extends Ga-68 Activities in Japan
EQS-News: Eckert & Ziegler Extends Ga-68 Activities in Japan
EQS-News: Eckert & Ziegler Extends Ga-68 Activities in Japan
Chemed Reports Fourth-Quarter 2023 Results
Chemed Reports Fourth-Quarter 2023 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual Raymond James

Agilent Reports First-Quarter Fiscal Year 2024 Financial ResultsPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.66 billion for the first quarter ended Jan. 31, 2024, a decline of 5.6% reported and 6.4% core(1) compared to the first quarter of

Acadia Healthcare Reports Fourth Quarter 2023 Results
Acadia Healthcare Reports Fourth Quarter 2023 Results


Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2023.



Fourth Quarter Highlights

QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

Humana Announces Strategic Partnership with Veda to Improve Accuracy of Provider Directories
Humana Announces Strategic Partnership with Veda to Improve Accuracy of Provider Directories


Leading health and well-being company Humana Inc. (NYSE: HUM) today announced a strategic partnership with Veda, a health technology company specializing in helping healthcare companies solve

Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference:
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference


Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024.



Bernard Zovighian, chief executive officer, and

EQS-News: MEDICLIN: Contract for the sale of the MEDICLIN Herzzentrum Coswig has been signed
EQS-News: MEDICLIN: Contract for the sale of the MEDICLIN Herzzentrum Coswig has been signed
EQS-News: MEDICLIN: Contract for the sale of the MEDICLIN Herzzentrum Coswig has been signed
Agilent Announces Cash Dividend of 23.6 Cents per SharePhoto, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
Agilent Announces Cash Dividend of 23.6 Cents per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on April 24, 2024, to all shareholders of record as of the close of

Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-ElectPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect


Agilent Technologies Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG), has been named CEO-elect and chief operating officer (COO) of the company

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024.



Financial

Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results


Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.



Full Year 2023 Key Highlights:




  • Consolidated revenue of $10.3 billion

STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today